PHAT
Phathom Pharmaceuticals Inc.
$11.74
+$0.53(+4.73%)
40
Overall
--
Value
40
Tech
--
Quality
Market Cap
$778.96M
Volume
560.66K
52W Range
$2.21 - $19.50
Target Price
$20.50
Key Metrics Overview
| Market Cap | $778.96M | P/E Ratio | N/A |
| 52W High | $19.50 | 52W Low | $2.21 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | -10.8% | 52W Position | 55.1% |
| Overall Score | 40 | Value Score | -- |
| Quality Score | -- | Technical Score | 40 |
Growth Analysis
| EPS Current Est | $-2.77 | EPS Next Est | $0.23 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PHAT | $11.74 | +4.7% | 560.66K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Phathom Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW